Astria Therapeutics(US:ATXS) Prnewswireยท2025-10-15 01:05Group 1 - Class Action Attorney Juan Monteverde's firm, Monteverde & Associates PC, has recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - The firm is investigating Astria Therapeutics, Inc. (NASDAQ: ATXS) regarding its proposed sale to BioCryst Pharmaceuticals, Inc., where Astria shareholders will receive $8.55 in cash per share and 0.59 shares of BioCryst common stock per Astria share [1] - The firm operates from the Empire State Building in New York City and emphasizes its successful track record in trial and appellate courts, including the U.S. Supreme Court [2] Group 2 - Monteverde & Associates PC offers free consultations for shareholders concerned about the proposed transaction and provides additional information through their website [1][2] - The firm encourages shareholders to inquire about their past recoveries and the specifics of their litigation success [4]